The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer

E. Boven, H. Schipper, C. A M Erkelens, S. A. Hatty, H. M. Pinedo

Research output: Contribution to journal › Article › peer-review